Fund

TEDA VC

泰达科投

TEDA VC (泰达科投) is an active Chinese venture capital firm that has been investing across biotech, semiconductor, and advanced manufacturing since at least 2021. It appears as both a follower and a lead investor: it followed in Shize Biotech's angel round in 2021 and participated in CoreX Technology's funding in 2023, then co-led a Series A1 round in physical intelligence startup FeiJieKeSi in August 2026 alongside Haison Capital and Fudan Sci-Tech Innovation . The firm also doubled down on portfolio companies, with its partners re-upping in Shize Biotech's later round . Elsewhere's corpus does not cover its founding date, AUM, or full team composition.

AI-generated — may contain errors, please verify.

TEDA VCFund
泰达科投
渲染中…
Mentioned in 6 articles

Coverage